Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
UK
Contact person: Linda Downie
Telephone: +44 1698794571
E-mail: l.downie@nhs.net
NUTS: UKM
Internet address(es)
Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/
Address of the buyer profile: http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Trastuzumab powder for reconstitution for intravenous infusion (IV) Vials
Reference number: NP47418
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Supply of trastuzumab powder for reconstitution for intravenous infusion to Health Boards across NHS Scotland. The procurement will include 150 mg and 420 mg vials.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
2 075 787.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
This Framework Agreement is for the supply of trastuzumab powder for reconstitution for intravenous infusion 150 mg and 420 mg vials to Health Boards across NHS Scotland.
Each product line was treated as an individual lot and awarded as an unranked multi supplier framework agreement. It was envisaged that each line would be awarded to a maximum of four (4)Framework Participants.
II.2.5) Award criteria
Quality criterion: Logistics
/ Weighting: 5
Price
/ Weighting:
95
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Access to contract pricing is required by the designated Compounding company for supply to Participating Authorities across NHS Scotland.
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2018/S 080-178672
Section V: Award of contract
Contract No: NP47418
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
10/07/2018
V.2.2) Information about tenders
Number of tenders received: 4
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Napp Pharmaceuticals
Milton Road, Science Park
Cambridge
CB4 0AB
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
MSD
Hertford Road
Hoddesdon
EN11 9BU
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Amgen Ltd
240 Cambridge Science Park, Milton Road
Cambridge
CB4 0WD
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Roche Products Ltd
6 Falcon Way, Shire Park
Welwyn Garden City
AL7 1TW
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 2 075 787.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The estimated values referred to in Section II.I.5) and II.2.6) covers the eighteen (18) months contract duration and the two (2) twelve (12) month extension periods of the framework agreement.
(SC Ref:552673)
VI.4) Procedures for review
VI.4.1) Review body
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
UK
Telephone: +44 1698794410
Internet address(es)
URL: http://www.nhsscotlandprocurement.scot.nhs.uk/
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
VI.5) Date of dispatch of this notice
08/08/2018